MPS Commercial was formalised as a company in 2011 to support patients with ultra-rare conditions taking part in clinical trials.


As our business continues to grow, we have been able to extend our services to provide patient focussed research and communications.

When you need disease insight that can only be gathered through talking directly to patients and their families, we are in the unparalleled position of having direct access to those with Fabry, mucopolysaccharide (MPS) and related lysosomal storage diseases in the UK.


Our established connections with international patient organisations and networks allows us to conduct global research studies, if required.


We understand the challenges of working in the rare disease sector. From the difficulties faced by a family wanting their child to participate in a clinical trial taking place hundreds of miles from their home, to the need to provide additional data to support reimbursement post approval; we have a thorough knowledge of the issues faced by companies working in the rare disease arena and the expertise and experience to support you. 

MPS Commercial is a wholly owned, not-for-profit subsidiary of the Society for Mucopolysaccharide Diseases (MPS Society) which is a registered charity.


Our social objectives are to invest any profits into the MPS community for the purposes of education, enhancing needs-led advocacy support, quality of

life research and scientific research.

We are proud of the contribution we are able to make to the work of the charity.  Recent grants awarded include:

An in-depth characterisation of Fabry patients with cardiac devices to predict risk of malignant arrhythmia and sudden cardiac death

Queen Elizabeth Hospital, Birmingham; Royal Free Hospital, University College London; Salford Royal NHS Foundation Trust, Manchester

A pilot study into the value of portable technologies in recording day-to-day patient monitored information in children and young people with Fabry disease

– Royal Free Hospital, University College London

Assessing the bioavailability of Genistein in patients with MPS II, MPS IVA and MPS VI

– Salford Royal NHS Foundation Trust, Manchester

Genotype-phenotype relationships in Fabry disease to stratify severity and understand heterogeneity using extended family pedigrees

– Royal Free Hospital, University College London

The MPS Society is the only registered UK charity providing professional support to individuals, families and professionals affected by MPS and related diseases throughout the UK.


+44 (0) 345 260 1087

MPS House, Repton Place

White Lion Road, Amersham, Buckinghamshire,


  • LinkedIn Social Icon

© 2018 MPS Commercial. MPS Commercial. All Rights Reserved. Website Design by AIM.